Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Reminyl (galantamine hydrobromide) - Important Safety Information from Shire Pharmaceuticals Ireland Ltd.
Notice type:
3rd Party Publications
Date:
10/11/2015
Problem Or Issue:
Important Safety Information communication from Shire Pharmaceuticals Ireland Ltd. on new warning on the risk of serious skin reactions, Stevens-Johnson syndrome and acute generalised exanthematous pustulosis associated with Reminyl (galantamine hydrobromide).
Important Safety Information - Reminyl (galantamine hydrobromide)
« Back
Date Printed: 28/03/2024